1-2 of 2
Bart A. Westerman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Real-world Toxicity Atlas Shows that Adverse Events of Combination Therapies Commonly Result in Additive Interactions

Open Access
Asli Küçükosmanoglu, Silvia Scoarta, Megan Houweling, Nicoleta Spinu, Thomas Wijnands, Niek Geerdink, Carolien Meskers, Georgi K. Kanev, Bert Kiewiet, Mathilde Kouwenhoven, David Noske, Tom Wurdinger, Marianne Pouwer, Mark Wolff, Bart A. Westerman
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (8): 1685–1695.
https://doi.org/10.1158/1078-0432.CCR-23-0914
Published: 15 April 2024
View articletitled, A Real-world Toxicity Atlas Shows that Adverse Events of Combination Therapies Commonly Result in Additive Interactions
Open the PDF for A Real-world Toxicity Atlas Shows that Adverse Events of Combination Therapies Commonly Result in Additive Interactions in another window
Includes: Supplementary data
Journal Articles

Quantitative Reverse Transcription-Polymerase Chain Reaction Measurement of HASH1 ( ASCL1 ), a Marker for Small Cell Lung Carcinomas with Neuroendocrine Features

Free
Bart A. Westerman, Sari Neijenhuis, Ankie Poutsma, Renske D. M. Steenbergen, Roderick H. J. Breuer, Monique Egging, Inge J. van Wijk, Cees B. M. Oudejans
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (4): 1082–1086.
Published: 01 April 2002
View articletitled, Quantitative Reverse Transcription-Polymerase Chain Reaction Measurement of HASH1 ( ASCL1 ), a Marker for Small Cell Lung Carcinomas with Neuroendocrine Features
Open the PDF for Quantitative Reverse Transcription-Polymerase Chain Reaction Measurement of HASH1 ( ASCL1 ), a Marker for Small Cell Lung Carcinomas with Neuroendocrine Features in another window